HK Stock MarketDetailed Quotes

01358 PW MEDTECH

Watchlist
  • 0.950
  • -0.020-2.06%
Trading Apr 18 14:35 CST
1.49BMarket Cap8.80P/E (TTM)

PW MEDTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
-31.71%247.35M
-41.07%101.54M
16.53%362.18M
20.50%172.31M
Operating income
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
-31.71%247.35M
-41.07%101.54M
16.53%362.18M
20.50%172.31M
Cost of sales
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
29.49%-98.75M
36.07%-42.02M
-21.19%-140.06M
-19.09%-65.73M
Operating expenses
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
29.49%-98.75M
36.07%-42.02M
-21.19%-140.06M
-19.09%-65.73M
Gross profit
27.46%380.9M
46.01%176.8M
79.95%298.83M
46.81%121.09M
11.74%166.06M
38.59%82.48M
-33.10%148.6M
-44.16%59.51M
13.77%222.13M
21.39%106.58M
Selling expenses
-12.77%-76.09M
-9.42%-39.22M
-9.21%-67.47M
-5.26%-35.84M
25.27%-61.78M
26.80%-34.05M
18.28%-82.67M
7.37%-46.52M
-38.73%-101.16M
-59.01%-50.23M
Administrative expenses
6.21%-119.02M
-30.29%-59.8M
-94.55%-126.9M
-70.49%-45.9M
-15.35%-65.23M
18.70%-26.92M
13.33%-56.55M
-7.51%-33.11M
-12.32%-65.24M
-158.87%-30.8M
Research and development expenses
-0.38%-41.13M
-67.79%-22.97M
-102.32%-40.98M
-85.88%-13.69M
55.75%-20.25M
31.12%-7.37M
-79.38%-45.77M
-9.33%-10.69M
5.17%-25.51M
20.02%-9.78M
Profit from asset sales
---6.1M
----
----
----
24.51%731.75M
495.22%731.75M
--587.72M
--122.94M
----
----
Revaluation surplus
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
-6.24%-1.75M
-2,690.19%-13.99M
---1.65M
--540K
-Changes in the fair value of investment property
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
-6.24%-1.75M
-2,690.19%-13.99M
---1.65M
--540K
Impairment and provision
----
----
----
----
-316.45%-40.69M
35.48%-4.09M
36.95%-9.77M
-32.08%-6.34M
-210.07%-15.5M
---4.8M
-Impairment of property, machinery and equipment
----
----
----
----
---40.69M
----
----
----
----
----
-Other impairment is provision
----
----
----
----
----
35.48%-4.09M
36.95%-9.77M
-32.08%-6.34M
-210.07%-15.5M
---4.8M
Special items of operating profit
-17.98%48.9M
-20.63%33.54M
446.14%59.61M
868.98%42.26M
19.89%-17.22M
14.49%-5.5M
-88.61%-21.5M
-238.62%-6.43M
42.24%-11.4M
92.98%-1.9M
Operating profit
52.55%187.4M
32.30%88.15M
-81.95%122.84M
-90.93%66.63M
31.34%680.73M
1,024.37%734.95M
30,918.25%518.32M
580.05%65.37M
-94.73%1.67M
90.11%9.61M
Financing income
25.12%43.67M
53.90%20.26M
-38.47%34.9M
--13.16M
1,206.71%56.73M
----
---5.13M
---9.27M
----
----
Financing cost
----
----
----
----
----
--30.89M
----
----
-388.74%-28.68M
-1,349.23%-14.67M
Share of profits of associates
----
----
----
----
----
----
0.52%113.41M
17.41%79.08M
11.97%112.82M
69.87%67.36M
Earning before tax
46.48%231.07M
35.86%108.41M
-78.61%157.75M
-89.58%79.79M
17.69%737.46M
466.52%765.84M
630.23%626.6M
116.98%135.18M
-32.21%85.81M
35.79%62.3M
Tax
9.82%-26.04M
-38.83%-11.54M
-1,847.13%-28.88M
-74.74%-8.31M
-68.28%1.65M
-179.67%-4.76M
235.76%5.21M
344.49%5.97M
65.30%-3.84M
66.21%-2.44M
After-tax profit from continuing operations
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
670.79%631.81M
135.80%141.15M
-29.04%81.97M
54.85%59.86M
Earning after tax
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
670.79%631.81M
135.80%141.15M
-95.08%81.97M
-96.23%59.86M
Minority profit
127.11%51.84M
138.53%25.9M
760,966.67%22.83M
542,950.00%10.86M
0.00%-3K
0.00%-2K
76.92%-3K
77.78%-2K
-101.86%-13K
-102.91%-9K
Profit attributable to shareholders
44.46%153.18M
17.07%70.98M
-85.65%106.04M
-92.03%60.63M
16.98%739.12M
439.20%761.09M
670.67%631.81M
135.77%141.15M
-95.08%81.98M
-96.23%59.87M
Basic earnings per share
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
671.26%0.4026
135.34%0.0899
-95.08%0.0522
-96.23%0.0382
Diluted earnings per share
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
671.26%0.4026
135.34%0.0899
-95.08%0.0522
-96.22%0.0382
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M-31.71%247.35M-41.07%101.54M16.53%362.18M20.50%172.31M
Operating income 25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M-31.71%247.35M-41.07%101.54M16.53%362.18M20.50%172.31M
Cost of sales -23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M29.49%-98.75M36.07%-42.02M-21.19%-140.06M-19.09%-65.73M
Operating expenses -23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M29.49%-98.75M36.07%-42.02M-21.19%-140.06M-19.09%-65.73M
Gross profit 27.46%380.9M46.01%176.8M79.95%298.83M46.81%121.09M11.74%166.06M38.59%82.48M-33.10%148.6M-44.16%59.51M13.77%222.13M21.39%106.58M
Selling expenses -12.77%-76.09M-9.42%-39.22M-9.21%-67.47M-5.26%-35.84M25.27%-61.78M26.80%-34.05M18.28%-82.67M7.37%-46.52M-38.73%-101.16M-59.01%-50.23M
Administrative expenses 6.21%-119.02M-30.29%-59.8M-94.55%-126.9M-70.49%-45.9M-15.35%-65.23M18.70%-26.92M13.33%-56.55M-7.51%-33.11M-12.32%-65.24M-158.87%-30.8M
Research and development expenses -0.38%-41.13M-67.79%-22.97M-102.32%-40.98M-85.88%-13.69M55.75%-20.25M31.12%-7.37M-79.38%-45.77M-9.33%-10.69M5.17%-25.51M20.02%-9.78M
Profit from asset sales ---6.1M------------24.51%731.75M495.22%731.75M--587.72M--122.94M--------
Revaluation surplus 75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M-6.24%-1.75M-2,690.19%-13.99M---1.65M--540K
-Changes in the fair value of investment property 75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M-6.24%-1.75M-2,690.19%-13.99M---1.65M--540K
Impairment and provision -----------------316.45%-40.69M35.48%-4.09M36.95%-9.77M-32.08%-6.34M-210.07%-15.5M---4.8M
-Impairment of property, machinery and equipment -------------------40.69M--------------------
-Other impairment is provision --------------------35.48%-4.09M36.95%-9.77M-32.08%-6.34M-210.07%-15.5M---4.8M
Special items of operating profit -17.98%48.9M-20.63%33.54M446.14%59.61M868.98%42.26M19.89%-17.22M14.49%-5.5M-88.61%-21.5M-238.62%-6.43M42.24%-11.4M92.98%-1.9M
Operating profit 52.55%187.4M32.30%88.15M-81.95%122.84M-90.93%66.63M31.34%680.73M1,024.37%734.95M30,918.25%518.32M580.05%65.37M-94.73%1.67M90.11%9.61M
Financing income 25.12%43.67M53.90%20.26M-38.47%34.9M--13.16M1,206.71%56.73M-------5.13M---9.27M--------
Financing cost ----------------------30.89M---------388.74%-28.68M-1,349.23%-14.67M
Share of profits of associates ------------------------0.52%113.41M17.41%79.08M11.97%112.82M69.87%67.36M
Earning before tax 46.48%231.07M35.86%108.41M-78.61%157.75M-89.58%79.79M17.69%737.46M466.52%765.84M630.23%626.6M116.98%135.18M-32.21%85.81M35.79%62.3M
Tax 9.82%-26.04M-38.83%-11.54M-1,847.13%-28.88M-74.74%-8.31M-68.28%1.65M-179.67%-4.76M235.76%5.21M344.49%5.97M65.30%-3.84M66.21%-2.44M
After-tax profit from continuing operations 59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M670.79%631.81M135.80%141.15M-29.04%81.97M54.85%59.86M
Earning after tax 59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M670.79%631.81M135.80%141.15M-95.08%81.97M-96.23%59.86M
Minority profit 127.11%51.84M138.53%25.9M760,966.67%22.83M542,950.00%10.86M0.00%-3K0.00%-2K76.92%-3K77.78%-2K-101.86%-13K-102.91%-9K
Profit attributable to shareholders 44.46%153.18M17.07%70.98M-85.65%106.04M-92.03%60.63M16.98%739.12M439.20%761.09M670.67%631.81M135.77%141.15M-95.08%81.98M-96.23%59.87M
Basic earnings per share 44.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485671.26%0.4026135.34%0.0899-95.08%0.0522-96.23%0.0382
Diluted earnings per share 44.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485671.26%0.4026135.34%0.0899-95.08%0.0522-96.22%0.0382
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg